The Greater Cannabis Company, Inc. (GCAN)
OTCMKTS · Delayed Price · Currency is USD
0.0540
-0.0062 (-10.30%)
At close: Dec 5, 2025
GCAN Market Cap
GCAN has a market cap or net worth of $51.03 thousand as of December 5, 2025. Its market cap has decreased by -86.21% in one year.
Market Cap
51.03K
Enterprise Value
312.56K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since September 18, 2018, GCAN's market cap has decreased from 4.11M to 51.03K, a decrease of -98.76%. That is a compound annual growth rate of -45.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 51.03K | -84.15% |
| Dec 31, 2024 | 321.86K | -51.31% |
| Dec 29, 2023 | 661.03K | 64.05% |
| Dec 30, 2022 | 402.95K | -74.44% |
| Dec 31, 2021 | 1.58M | 13.07% |
| Dec 31, 2020 | 1.39M | 13.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 558.58M |
| Glass House Brands | 531.36M |
| CytoDyn | 403.93M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 364.92M |
| Silence Therapeutics | 336.78M |
| Nika Pharmaceuticals | 259.91M |